NEW YORK, NY / ACCESSWIRE / June 11, 2018 / U.S. markets finished higher and logged strongest week in months as investors shrug off tensions between U.S. and its allies. The Dow Jones Industrial Average increased 0.30 percent to close at 25,316.53, while the S&P 500 Index gained 0.31 percent to close at 2,779.03. The Nasdaq Composite Index was up 0.14 percent to close at 7,645.51 .For the week, the Dow jumped 2.8%, its biggest weekly gain in more than two months. The S&P hiked 1.6% and the Nasdaq rose 1.2%, posting their third straight weekly gain.

"I wouldn't have been surprised to have a down day in advance of G-7, and I find it very encouraging that markets are trending higher right now, it's a sign of resilience," said Leo Grohowski, chief investment officer at BNY Mellon Wealth Management. "Investors have been wise to not trade on trade talk and drama; we're in a war of words, but not a trade war. If that persists, then I'm not inclined to adjust our GDP or earnings estimates," Grohowski added.

RDI Initiates Coverage on:

Teva Pharmaceutical Industries Ltd.
https://rdinvesting.com/news/?ticker=TEVA

Horizon Pharma PLC
https://rdinvesting.com/news/?ticker=HZNP

Teva Pharmaceutical's stock jumped 5.57% Friday, to close the day at $23.11. The stock recorded a trading volume of 22,321,602 shares, which was above its three months average volume of 11,701,009 shares. In the last year, Teva Pharmaceutical's shares have traded in a range of 10.85 - 33.82. The share price has gained 113% from its 52 week low. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $20.06 is above its 200-day moving average of $18.86. Shares of Teva Pharmaceutical have gained roughly 20.11 percent in the past month and are up 21.95 percent year-to-date.

Access RDI's Teva Pharmaceutical Industries Ltd. Research Report at:
https://rdinvesting.com/news/?ticker=TEVA

On Friday, shares of Horizon Pharma recorded a trading volume of 3,507,036 shares, which was above the three months average volume of 1,875,055 shares. The stock ended the day 5.63% higher at $17.26. The share price has fallen 4.69% from its 52 week high with a 52 week trading range of 10.10 - 18.11. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $15.00 is above its 200-day moving average of $14.68. Shares of Horizon Pharma have gained roughly 25.71 percent in the past month and are up 18.22 percent year-to-date.

Access RDI's Horizon Pharma PLC Research Report at:
https://rdinvesting.com/news/?ticker=HZNP

Our Actionable Research on Teva Pharmaceutical Industries Ltd. (NYSE :TEVA) and Horizon Pharma PLC (NASDAQ :HZNP) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker-dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com